SS Innovations Names Milan Rao as Global COO and CFO, Effective January 16

SSII
January 09, 2026

SS Innovations International, Inc. (NASDAQ: SSII) announced that Milan Rao will assume the newly created role of Global Chief Operating Officer and the existing position of Chief Financial Officer, with his responsibilities taking effect on January 16, 2026.

Rao brings more than 30 years of executive experience across technology, healthcare, and finance. He has served as COO and CRO at Markets and Markets, President of Wipro Limited, and President & CEO for India and Emerging Markets at GE Healthcare. His academic credentials include a B.S. in Computer Science and Engineering from IIT Varanasi and an MBA in Finance and Marketing from IIM Calcutta.

SS Innovations develops the SSi Mantra surgical robotic system and SSi Mudra instruments, aiming to make robotic surgery affordable worldwide. The company’s revenue grew 40.8 % to $5.1 million in Q1 2025 versus $3.0 million in Q1 2024, and 192.5 % to $12.8 million in Q3 2025 versus $4.1 million in Q3 2024. Despite strong top‑line growth, the firm remains unprofitable, reporting net losses of $5.7 million in Q1 2025 and $3.7 million in Q3 2025, and faces a limited cash runway as it pursues FDA 510(k) clearance and CE marking for its flagship system.

The appointment is a strategic response to the company’s need for disciplined capital allocation and operational scaling as it prepares for regulatory milestones and potential financing rounds. Rao’s track record in global operations and finance is expected to strengthen execution on the company’s growth strategy, improve cost discipline, and support the capital structure required for future product launches and market expansion.

Dr. Sudhir Srivastava, Chairman and CEO, said, “Milan brings a commendable track record of building high‑performance teams and growing multinational businesses through hands‑on leadership. He will play an integral role in defining our growth strategy and delivering on our promise of democratizing robotic surgery.”

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.